Rand Wealth’s AstraZeneca AZN Stock Holding History

Rand Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-4,975	Closed	-$235K	–	185
2013 Q2	$235K	Buy	+4,975	New	+$253K	0.05%	173

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Rand Wealth's AZN Position: Q3 2013 in Review

Rand Wealth sold out of AstraZeneca (AZN) in Q3 2013, closing a stake of 4,975 shares — an estimated $235K sold.

Rand Wealth first reported a position in AZN in Q2 2013 and held it in 1 quarter. The position peaked at $235K in Q2 2013. 343 funds tracked by Wall St. Rank hold AZN as of Q3 2013.

Rand Wealth reported no remaining AstraZeneca position as of Q3 2013 after selling out during the quarter.
Rand Wealth sold 4,975 AstraZeneca shares in Q3 2013, an estimated $235K.
Rand Wealth first reported a position in AstraZeneca in Q2 2013 and held it in 1 quarter.
Rand Wealth's AstraZeneca position peaked at $235K in Q2 2013.
343 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2013.

Based on Rand Wealth's 13F filing for Q3 2013, filed 21 Oct 2013.